Peng Zhu

10PUBLICATIONS
25CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 05, 2025
Risk factors for hepatocellular carcinoma rupture: multicentre retrospective study.

Feng Xia, Yiyang Liu, Hongwei Huang

|Oct 10, 2025
VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization.

Chen Su, Zhibin Liao, Jie Mo

|Apr 29, 2025
Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients.

Wei Wang, Chen Dai, Peng Zhu

|Jan 20, 2025
Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in China.

Feng Xia, Qian Chen, Zhicheng Liu

|Jun 19, 2024
Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study.

Xulin Liu, Zhancheng Qiu, Elijah Ndhlovu

|Jan 27, 2024
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation.

Chen Su, Haoquan Zhang, Jie Mo

Pageof 2

Frequent Collaborators

2 joint publications

Xiaosheng Tan

2 joint publications

Xiufang Weng

1 joint publications

Xue Cheng

1 joint publications

Wei Wang